Microbio Co., Ltd.

ISIN TW0004128004

 | 

WKN A0RNR6

Market cap (in EUR)
286 m
Country
Taiwan
Sector
Consumer Non-Cyclicals
Dividend yield
0.11%
 

Overview

Description

Microbio Co., Ltd. engages in the research, development, manufacture, and sale of new drugs and healthcare products. The company also supplies raw materials to pharmaceutical companies in Taiwan. Its major products include health food, herbal products, botanical drugs, and disease prevention and nutrients supplements. The company was founded in May 3, 2000 and is headquartered in Taipei, Taiwan.
Show more Show less
Consumer Non-Cyclicals Food and Staples Retail Food and Beverage Retail Taiwan

Financials

Key metrics

Market capitalisation, EUR 286 m
EPS, EUR -0.05
P/B ratio 1.2
P/E ratio 149.5
Dividend yield 0.11%

Income statement (2024)

Revenue, EUR 50 m
Net income, EUR -32 m
Profit margin -63.89%

What ETF is Microbio Co., Ltd. in?

There are 4 ETFs which contain Microbio Co., Ltd.. All of these ETFs are listed in the table below. The ETF with the largest weighting of Microbio Co., Ltd. is the iShares MSCI Emerging Markets Small Cap UCITS ETF.
ETF Weight Investment focus Fund size (in m EUR)
iShares MSCI Emerging Markets Small Cap UCITS ETF 0.02%
Equity
Emerging Markets
Small Cap
300
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.00%
Equity
World
Social/Environmental
491
Vanguard ESG Emerging Markets All Cap UCITS ETF (USD) Distributing 0.00%
Equity
Emerging Markets
Social/Environmental
15
iShares MSCI EM IMI Screened UCITS ETF USD (Dist) 0.01%
Equity
Emerging Markets
Social/Environmental
1,187
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.